LIMNW
Financials
- Market Capitalization 5.6818 M
- Employee 1
- Founded N/A
- CEO N/A
- Website liminatuspharma.com
- Headquarter Delaware, United States
- FIGI BBG01HVYG111
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5300 |  GRFS Grifols, S.A. - American Depositary Shares | 7.69 USD | -1.66% | -3.88% | -7.57% | -21.21% | 0 USD | ||
| 7287 |  SCLXW Scilex Holding Company - Warrant | 0.1579 USD | 0.00% | +20.53% | -16.89% | -65.67% | 46.12 M USD | ||
| 7357 |  MDCXW Medicus Pharma Ltd. - Warrant | 0.3302 USD | 0.00% | 0.00% | -33.95% | -57.65% | 16.43 M USD | ||
| 7383 |  ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0590 USD | -24.36% | +7.66% | +2.61% | -41.00% | 7.46 M USD |
Frequently asked questions about Liminatus Pharma, Inc. Class A Common Stock
What is the Liminatus Pharma, Inc. Class A Common Stock stock price today?
The current price of Liminatus Pharma, Inc. Class A Common Stock (LIMNW) is 0.0435. Over the past 24 hours, the stock has changed by -35.65%. Follow the LIMNW chart for real-time price dynamics.
What is the stock ticker of Liminatus Pharma, Inc. Class A Common Stock?
Liminatus Pharma, Inc. Class A Common Stock trades under the ticker LIMNW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Liminatus Pharma, Inc. Class A Common Stock stock going up?
LIMNW has changed by -3.33% over the last week, -45.15% over the last month, and -79.62% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Liminatus Pharma, Inc. Class A Common Stock?
Liminatus Pharma, Inc. Class A Common Stock currently has a market capitalization of 5.68 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Liminatus Pharma, Inc. Class A Common Stock earnings last quarter?
Last quarter, Liminatus Pharma, Inc. Class A Common Stock reported earnings of -1.5 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Liminatus Pharma, Inc. Class A Common Stock net income for the last quarter?
Liminatus Pharma, Inc. Class A Common Stock reported net income of -1.41 M for the last quarter. The previous quarter showed -1.12 M, which means net income changed by -25.23%.
How many employees does Liminatus Pharma, Inc. Class A Common Stock have?
As of the latest available data, Liminatus Pharma, Inc. Class A Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Liminatus Pharma, Inc. Class A Common Stock stock?
You can buy Liminatus Pharma, Inc. Class A Common Stock (LIMNW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Liminatus Pharma, Inc. Class A Common Stock stock?
Investing in Liminatus Pharma, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LIMNW chart and related analysis on metatrader.com as part of your research.